666 related articles for article (PubMed ID: 31330533)
1. Potential roles of gut microbiome and metabolites in modulating ALS in mice.
Blacher E; Bashiardes S; Shapiro H; Rothschild D; Mor U; Dori-Bachash M; Kleimeyer C; Moresi C; Harnik Y; Zur M; Zabari M; Brik RB; Kviatcovsky D; Zmora N; Cohen Y; Bar N; Levi I; Amar N; Mehlman T; Brandis A; Biton I; Kuperman Y; Tsoory M; Alfahel L; Harmelin A; Schwartz M; Israelson A; Arike L; Johansson MEV; Hansson GC; Gotkine M; Segal E; Elinav E
Nature; 2019 Aug; 572(7770):474-480. PubMed ID: 31330533
[TBL] [Abstract][Full Text] [Related]
2. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.
Zhang Y; Ogbu D; Garrett S; Xia Y; Sun J
Gut Microbes; 2021; 13(1):1996848. PubMed ID: 34812107
[TBL] [Abstract][Full Text] [Related]
3. Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect.
Gotkine M; Kviatcovsky D; Elinav E
Gut Microbes; 2020 Nov; 11(6):1833-1841. PubMed ID: 32501768
[TBL] [Abstract][Full Text] [Related]
4. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice.
Figueroa-Romero C; Guo K; Murdock BJ; Paez-Colasante X; Bassis CM; Mikhail KA; Pawlowski KD; Evans MC; Taubman GF; McDermott AJ; O'Brien PD; Savelieff MG; Hur J; Feldman EL
Dis Model Mech; 2019 Nov; 13(2):. PubMed ID: 31597644
[TBL] [Abstract][Full Text] [Related]
5. The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis.
Cox LM; Calcagno N; Gauthier C; Madore C; Butovsky O; Weiner HL
Microbiome; 2022 Mar; 10(1):47. PubMed ID: 35272713
[TBL] [Abstract][Full Text] [Related]
6. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
7. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
[TBL] [Abstract][Full Text] [Related]
8. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
[TBL] [Abstract][Full Text] [Related]
9. The molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly
Malik R; Meng H; Wongkongkathep P; Corrales CI; Sepanj N; Atlasi RS; Klärner FG; Schrader T; Spencer MJ; Loo JA; Wiedau M; Bitan G
J Biol Chem; 2019 Mar; 294(10):3501-3513. PubMed ID: 30602569
[TBL] [Abstract][Full Text] [Related]
10. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
[TBL] [Abstract][Full Text] [Related]
11. A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis.
Tokuda E; Nomura T; Ohara S; Watanabe S; Yamanaka K; Morisaki Y; Misawa H; Furukawa Y
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2119-2130. PubMed ID: 29551730
[TBL] [Abstract][Full Text] [Related]
12. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
13. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.
Leyton-Jaimes MF; Benaim C; Abu-Hamad S; Kahn J; Guetta A; Bucala R; Israelson A
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10198-203. PubMed ID: 27551074
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic CD8
Coque E; Salsac C; Espinosa-Carrasco G; Varga B; Degauque N; Cadoux M; Crabé R; Virenque A; Soulard C; Fierle JK; Brodovitch A; Libralato M; Végh AG; Venteo S; Scamps F; Boucraut J; Laplaud D; Hernandez J; Gergely C; Vincent T; Raoul C
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2312-2317. PubMed ID: 30674678
[TBL] [Abstract][Full Text] [Related]
15. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)
Silverman JM; Christy D; Shyu CC; Moon KM; Fernando S; Gidden Z; Cowan CM; Ban Y; Stacey RG; Grad LI; McAlary L; Mackenzie IR; Foster LJ; Cashman NR
J Biol Chem; 2019 Mar; 294(10):3744-3759. PubMed ID: 30635404
[TBL] [Abstract][Full Text] [Related]
16. Gut inflammation and dysbiosis in human motor neuron disease.
Rowin J; Xia Y; Jung B; Sun J
Physiol Rep; 2017 Sep; 5(18):. PubMed ID: 28947596
[TBL] [Abstract][Full Text] [Related]
17. A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model.
Tsuburaya N; Homma K; Higuchi T; Balia A; Yamakoshi H; Shibata N; Nakamura S; Nakagawa H; Ikeda SI; Umezawa N; Kato N; Yokoshima S; Shibuya M; Shimonishi M; Kojima H; Okabe T; Nagano T; Naguro I; Imamura K; Inoue H; Fujisawa T; Ichijo H
Nat Commun; 2018 Jul; 9(1):2668. PubMed ID: 29991716
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
19. The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1
Hilton JB; Kysenius K; White AR; Crouch PJ
Exp Neurol; 2018 Sep; 307():118-128. PubMed ID: 29906423
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
